Premium
Findling receives national award for bipolar research
Publication year - 2019
Publication title -
mental health weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7583
pISSN - 1058-1103
DOI - 10.1002/mhw.32102
Subject(s) - discontinuation , bipolar disorder , lithium (medication) , psychiatry , placebo , psychology , double blind , treatment of bipolar disorder , medicine , pediatrics , alternative medicine , mania , pathology
Kennedy Krieger Institute Vice President of Psychiatric Services and Research Robert Findling, M.D. , recently received the American Academy of Child and Adolescent Psychiatry's (AACAP's) 2019 Norbert and Charlotte Rieger Award for Scientific Achievement for his research on the role of lithium in the maintenance treatment of pediatric patients with bipolar I disorder. The award, which was presented Oct. 16 at the AACAP annual meeting in Chicago, recognizes the most outstanding scientific paper published in the Journal of the American Academy of Child and Adolescent Psychiatry from July 2018 through June 2019, a news release stated. Published in February 2019, the study, “Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double‐Blind, Placebo‐Controlled Discontinuation Study,” examines the long‐term safety of lithium through a randomized, double‐blind, placebo‐controlled discontinuation trial. The study found that continued treatment with lithium is associated with better outcomes and is generally well‐tolerated in pediatric patients with bipolar disorder.